1h Free Analyst Time
The publisher has been monitoring the multiplex assays market and it is poised to grow by $1.34 bn during 2022-2026, accelerating at a CAGR of 7.7% during the forecast period. The report on the multiplex assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by predictive and preventive medicine for early diagnosis and treatment, an increase in chronic diseases, and advancements in laboratory automation platforms.
The multiplex assays market analysis includes type segment and geographic landscape.
The multiplex assays market is segmented as below:
By Type
- Protein multiplex assays
- Nucleic acid multiplex assays
- Cell-based multiplex assays
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the launch of multiplex assay-based technologies as one of the prime reasons driving the multiplex assays market growth during the next few years. Also, emergence of new disease targets and increased usage of solid-phase magnetic beads for isolation and detection of biomolecules acts will lead to sizable demand in the market.
The report on the multiplex assays market covers the following areas:
- Multiplex assays market sizing
- Multiplex assays market forecast
- Multiplex assays market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading multiplex assays market vendors that include Abcam plc, Agilent Technologies Inc., Antigenix America Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio-Techne Corp., Cayman Chemical Co., DiaSorin SpA, Enzo Biochem Inc., Illumina Inc., Merck KGaA, Meso Scale Diagnostics LLC, PerkinElmer Inc., Promega Corp., QIAGEN NV, Quanterix Corp., Randox Laboratories Ltd., Seegene Inc., Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc. Also, the multiplex assays market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global multiplex assays market: Abcam plc, Agilent Technologies Inc., Antigenix America Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio-Techne Corp., Cayman Chemical Co., DiaSorin SpA, Enzo Biochem Inc., Illumina Inc., Merck KGaA, Meso Scale Diagnostics LLC, PerkinElmer Inc., Promega Corp., QIAGEN NV, Quanterix Corp., Randox Laboratories Ltd., Seegene Inc., Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the launch of multiplex assay-based technologies.`
According to the report, one of the major drivers for this market is predictive and preventive medicine for early diagnosis and treatment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam plc
- Agilent Technologies Inc.
- Antigenix America Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- Cayman Chemical Co.
- DiaSorin SpA
- Enzo Biochem Inc.
- Illumina Inc.
- Merck KGaA
- Meso Scale Diagnostics LLC
- PerkinElmer Inc.
- Promega Corp.
- QIAGEN NV
- Quanterix Corp.
- Randox Laboratories Ltd.
- Seegene Inc.
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
